Journal article
Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes
- Abstract:
-
Objective- The efficacy and safety of adding liraglutide (a glucagon-like peptide-1 receptor agonist) to metformin were compared with addition of placebo or glimepiride to metformin in subjects previously treated with oral antidiabetes (OAD) therapy. Research design and methods- In this 26-week, double-blind, double-dummy, placebo- and active-controlled, parallel-group trial, 1,091 subjects were randomly assigned (2:2:2:1:2) to once-daily liraglutide (either 0.6, 1.2, or 1.8 mg/day injected s...
Expand abstract
Actions
Authors
Bibliographic Details
- Journal:
- Diabetes Care
- Volume:
- 32
- Issue:
- 1
- Pages:
- 84-90
- Publication date:
- 2009-01-01
- DOI:
- EISSN:
-
1935-5548
- ISSN:
-
0149-5992
- Source identifiers:
-
95008
Item Description
- Language:
- English
- Pubs id:
-
pubs:95008
- UUID:
-
uuid:8c284677-66f0-4e58-9b91-485f893c2811
- Local pid:
- pubs:95008
- Deposit date:
- 2012-12-19
Terms of use
- Copyright date:
- 2009
If you are the owner of this record, you can report an update to it here: Report update to this record